Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.78M | 30.79M | 28.20M | 21.14M | 20.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.06M | 55.19M | 50.28M | 41.15M | 63.30M |
| Operating Income | -66.06M | -55.19M | -50.28M | -41.15M | -63.30M |
| Income Before Tax | -62.10M | -52.40M | -47.25M | -34.82M | -58.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -62.10 | -52.40 | -47.25 | -34.82 | -58.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Income | -62.10M | -52.40M | -47.25M | -34.82M | -58.52M |
| EBIT | -66.06M | -55.19M | -50.28M | -41.15M | -63.30M |
| EBITDA | -66.05M | -46.80M | -31.07M | -11.76M | -- |
| EPS Basic | -0.72 | -0.55 | -0.58 | -0.49 | -1.63 |
| Normalized Basic EPS | -0.45 | -0.43 | -0.45 | -0.41 | -0.95 |
| EPS Diluted | -0.72 | -0.55 | -0.58 | -0.49 | -1.63 |
| Normalized Diluted EPS | -0.45 | -0.43 | -0.45 | -0.41 | -0.95 |
| Average Basic Shares Outstanding | 346.19M | 300.15M | 256.25M | 215.79M | 175.14M |
| Average Diluted Shares Outstanding | 346.19M | 300.15M | 256.25M | 215.79M | 175.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |